Chemoinformaics analysis of RIBOSOME-INACTIVATING-PROTEIN
| Molecular Weight | 584.706 | nRot | 4 |
| Heavy Atom Molecular Weight | 540.354 | nRig | 32 |
| Exact Molecular Weight | 584.299 | nRing | 6 |
| Solubility: LogS | -4.581 | nHRing | 3 |
| Solubility: LogP | 3.012 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 5 |
| nHA | 9 | APOL | 91.6669 |
| nHD | 2 | BPOL | 54.5571 |
| QED | 0.3 |
| Synth | 5.768 |
| Natural Product Likeliness | 3.426 |
| NR-PPAR-gamma | 0.934 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.998 |
| HIA | 0.146 |
| CACO-2 | -5.022 |
| MDCK | 0.0000727 |
| BBB | 0.745 |
| PPB | 0.960467 |
| VDSS | 2.906 |
| FU | 0.0604662 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.163 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.844 |
| CYP2c9-inh | 0.287 |
| CYP2c9-sub | 0.057 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.156 |
| CYP3a4-inh | 0.584 |
| CYP3a4-sub | 0.807 |
| CL | 13.417 |
| T12 | 0.031 |
| hERG | 0.04 |
| Ames | 0.02 |
| ROA | 0.908 |
| SkinSen | 0.023 |
| Carcinogencity | 0.041 |
| EI | 0.005 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.685 |
| Antiviral | Yes |
| Prediction | 0.816259 |